You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dexamethasone (E-KRd)

Showing 1 - 25 of 6,920
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Chicago, Evanston, Ann Arbor (Elotuzumab, Carfilzomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +2 more
Nov 12, 2021

Newly Diagnosed Multiple Myeloma Trial in Austria, Germany (Elotuzumab, Carfilzomib, Lenalidomide)

Active, not recruiting
  • Newly Diagnosed Multiple Myeloma
  • Krems, Lower Austria, Austria
  • +55 more
Jan 4, 2022

Multiple Myeloma, New Diagnosis Tumor Trial in Italy (Carfilzomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • New Diagnosis Tumor
  • Alessandria, Italy
  • +41 more
Mar 24, 2022

Multiple Myeloma Trial in Worldwide (Carfilzomib Lenalidomide Dexamethasone, Isatuximab Carfilzomib Lenalidomide Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib Lenalidomide Dexamethasone
  • Isatuximab Carfilzomib Lenalidomide Dexamethasone
  • Ostrava, Czechia
  • +6 more
Jul 26, 2022

Multiple Myeloma Trial in Austria, Germany (Carfilzomib, Thalidomide, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Graz, Austria
  • +20 more
Jan 18, 2022

Long-term KRd in Relapsed and/or Refractory Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Aug 8, 2022

Multiple Myeloma Trial in Chicago (Carfilzomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jun 7, 2021

Myeloma Trial in Denmark, Norway, Sweden (Carfilzomib, Lenalidomide, PET-CT)

Recruiting
  • Myeloma
  • Copenhagen, Denmark
  • +3 more
Sep 15, 2021

Multiple Myeloma Trial in Portugal (Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Almada, Portugal
  • +11 more
Jun 27, 2022

Multiple Myeloma Trial in Charlotte (Elotuzumab)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 24, 2023

Multiple Myeloma Trial in France (Isatuximab, ASCT)

Recruiting
  • Multiple Myeloma
  • AMIENS Cedex 1, France
  • +67 more
Mar 28, 2022

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Columbus (procedure, drug, biological)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Biospecimen Collection
  • +9 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 1, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Fountain Valley, California
  • +107 more
Dec 7, 2022

Multiple Myeloma Trial in Germany (Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD),

Not yet recruiting
  • Multiple Myeloma
  • Allogeneic Stem Cells
  • +8 more
  • Freiburg, Baden-Württemberg, Germany
  • +31 more
Jan 5, 2023

Relapsed and/or Refractory Multiple Myeloma Trial in Japan (Ixazomib, Bortezomib, Carfilzomib)

Completed
Has Results
  • Relapsed and/or Refractory Multiple Myeloma
  • Kamogawa, Chiba, Japan
  • +22 more
Jul 27, 2022

Patients Undergoing Ankle Surgery Trial in New York (A. Control Nerve Block. IV Dexamethasone (4 mg)., B. Nerve Block with

Completed
Has Results
  • Patients Undergoing Ankle Surgery
  • A. Control Nerve Block. IV Dexamethasone (4 mg).
  • +4 more
  • New York, New York
    Hospital for Special Surgery
Apr 12, 2022

Multiple Myeloma Trial in Italy, Netherlands (CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE)

Active, not recruiting
  • Multiple Myeloma
  • CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE
  • Rionero In Vulture, PZ, Italy
  • +12 more
Mar 24, 2022

Multiple Myeloma Trial (Dexamethasone, Isatuximab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jan 10, 2023

COVID-19, Acute Respiratory Distress Syndrome, Pneumonia, Viral Trial in Madrid (Dexamethasone)

Recruiting
  • COVID-19
  • +2 more
  • Madrid, Spain
  • +2 more
Aug 3, 2022

Dry Eye Trial in Baltimore (Sustained Release Dexamethasone, 0.4 mg, E-Caprolactone-L-Lactide copolymer (PCL) punctal plug)

Recruiting
  • Dry Eye
  • Sustained Release Dexamethasone, 0.4 mg
  • E-Caprolactone-L-Lactide copolymer (PCL) punctal plug
  • Baltimore, Maryland
    Wilmer Eye Institute, Johns Hopkins School of Medicine
Jan 24, 2022

Multiple Myeloma Trial in Seoul (Lenalidomide maintenance)

Recruiting
  • Multiple Myeloma
  • Lenalidomide maintenance
  • Seoul, Korea, Republic of
    Samsung Medical Center
Aug 10, 2022

Multiple Myeloma Trial in Torino (Carfilzomib, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Mar 24, 2022

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (BGB-11417, Dexamethasone, Carfilzomib)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Birmingham, Alabama
  • +21 more
Aug 8, 2022

Multiple Myeloma Trial in Sweden, United States (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +8 more
Nov 23, 2021

Smoldering Myeloma, Smoldering Multiple Myeloma Trial in United States (Elotuzumab, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Smoldering Myeloma
  • Smoldering Multiple Myeloma
  • Denver, Colorado
  • +8 more
Nov 1, 2021